Non-traditional risk factors predict coronary calcification in chronic kidney disease in a population-based cohort (Q46853948)

25 December 2017

title

Non-traditional risk factors predict coronary calcification in chronic kidney disease in a population-based cohort (English)

1 reference

25 December 2017

chronic renal insufficiency

main subject

1 reference

U Baber

1

1 reference

25 December 2017

J A de Lemos

2

1 reference

25 December 2017

A Khera

3

1 reference

25 December 2017

D K McGuire

4

1 reference

25 December 2017

T Omland

5

1 reference

25 December 2017

R D Toto

6

1 reference

25 December 2017

S S Hedayati

7

1 reference

25 December 2017

language of work or name

English

0 references

publication date

12 December 2007

1 reference

25 December 2017

published in

Kidney International

1 reference

25 December 2017

volume

73

1 reference

25 December 2017

issue

5

1 reference

25 December 2017

page(s)

615-621

1 reference

25 December 2017

https://scigraph.springernature.com/pub.10.1038/sj.ki.5002716

exact match

0 references

cites work

Clinical epidemiology of cardiac disease in dialysis patients: left ventricular hypertrophy, ischemic heart disease, and cardiac failure

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002716

7 January 2021

Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002716

7 January 2021

Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002716

7 January 2021

Level of kidney function as a risk factor for atherosclerotic cardiovascular outcomes in the community

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002716

7 January 2021

Level of kidney function as a risk factor for cardiovascular outcomes in the elderly

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002716

7 January 2021

Cardiovascular disease risk factors in chronic kidney disease: overall burden and rates of treatment and control.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002716

7 January 2021

Prediction of coronary events with electron beam computed tomography

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002716

7 January 2021

Electron-beam tomography coronary artery calcium and cardiac events: a 37-month follow-up of 5635 initially asymptomatic low- to intermediate-risk adults.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002716

7 January 2021

Coronary artery calcium area by electron-beam computed tomography and coronary atherosclerotic plaque area. A histopathologic correlative study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002716

7 January 2021

Prevalence and predictors of cardiovascular calcium in chronic kidney disease (from the Prospective Longitudinal RRI-CKD Study).

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002716

7 January 2021

Determinants of coronary artery calcification in diabetics with and without nephropathy.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002716

7 January 2021

Coronary artery, aortic wall, and valvular calcification in nondialyzed individuals with type 2 diabetes and renal disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002716

7 January 2021

Cardiovascular calcification in Hispanic Americans (HA) with chronic kidney disease (CKD) due to type 2 diabetes.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002716

7 January 2021

The impact of traditional and non-traditional risk factors on coronary calcification in pre-dialysis patients.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002716

7 January 2021

Serum phosphate levels and mortality risk among people with chronic kidney disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002716

7 January 2021

Mineral metabolism, mortality, and morbidity in maintenance hemodialysis.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002716

7 January 2021

Progression of coronary artery calcification in predialysis patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002716

7 January 2021

Coronary artery calcification in patients with CRF not undergoing dialysis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002716

7 January 2021

Relation between serum phosphate level and cardiovascular event rate in people with coronary disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002716

7 January 2021

Hyperhomocysteinemia, hyperfibrinogenemia, and lipoprotein (a) excess in maintenance dialysis patients: a matched case-control study.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002716

7 January 2021

The prevalence of nontraditional risk factors for coronary heart disease in patients with chronic kidney disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002716

7 January 2021

Hyperhomocysteinaemia: a significant risk factor for cardiovascular disease in renal transplant recipients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002716

7 January 2021

Prospective study of hyperhomocysteinemia as an adverse cardiovascular risk factor in end-stage renal disease.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002716

7 January 2021

The graded effect of hyperhomocysteinemia on the severity and extent of coronary atherosclerosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002716

7 January 2021

Plasma homocysteine predicts progression of atherosclerosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002716

7 January 2021

Effect of homocysteine lowering on mortality and vascular disease in advanced chronic kidney disease and end-stage renal disease: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002716

7 January 2021

Osteoprotegerin: a novel secreted protein involved in the regulation of bone density

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002716

7 January 2021

osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002716

7 January 2021

Relation of osteoprotegerin to coronary calcium and aortic plaque (from the Dallas Heart Study).

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002716

7 January 2021

Serum levels of calcification inhibition proteins and coronary artery calcium score: comparison between transplantation and dialysis.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002716

7 January 2021

The progression of vascular calcification and serum osteoprotegerin levels in patients on long-term hemodialysis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002716

7 January 2021

Serum osteoprotegerin levels are associated with the presence and severity of coronary artery disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002716

7 January 2021

Plasma osteoprotegerin is associated with mortality in hemodialysis patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002716

7 January 2021

Serum osteoprotegerin and renal osteodystrophy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002716

7 January 2021

Evidence for abnormal calcium homeostasis in patients with adynamic bone disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002716

7 January 2021

Prognostic value of combined use of biomarkers of inflammation, endothelial dysfunction, and myocardiopathy in patients with ESRD.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002716

7 January 2021

Pathogenesis of vascular calcification in chronic kidney disease.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002716

7 January 2021

The Dallas Heart Study: a population-based probability sample for the multidisciplinary study of ethnic differences in cardiovascular health.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002716

7 January 2021

A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002716

7 January 2021

Quantification of coronary artery calcium using ultrafast computed tomography.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002716

7 January 2021

Multi-Ethnic Study of Atherosclerosis: objectives and design

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002716

7 January 2021

Coronary artery calcium score, risk factors, and incident coronary heart disease events

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002716

7 January 2021

Electron beam computed tomographic coronary calcium scanning: a review and guidelines for use in asymptomatic persons

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002716

7 January 2021

Coronary calcification improves cardiovascular risk prediction in the elderly

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002716

7 January 2021

Coronary Artery Calcium Score Combined With Framingham Score for Risk Prediction in Asymptomatic Individuals

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002716

7 January 2021

Coronary Calcification, Coronary Disease Risk Factors, C-Reactive Protein, and Atherosclerotic Cardiovascular Disease Events

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002716

7 January 2021

Sex and age differences in lipoprotein subclasses measured by nuclear magnetic resonance spectroscopy: the Framingham Study.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002716

7 January 2021

Increased serum osteoprotegerin in disorders characterized by persistent immune activation or glucocorticoid excess--possible role in bone homeostasis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002716

7 January 2021

Race and gender differences in C-reactive protein levels

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002716

7 January 2021

Identifiers

DOI

10.1038/SJ.KI.5002716

1 reference

25 December 2017

PubMed ID

18075501

1 reference

25 December 2017